Cotinine Feedback as an Intervention to Change Parental/Caregiver Smoking Behavior Around Children With Cancer
NCT ID: NCT01828502
Last Updated: 2014-10-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE2
INTERVENTIONAL
2013-10-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This randomized study will compare education only to education plus cotinine feedback in decreasing secondhand smoke exposure in pediatric patients with cancer that reside with a household smoker.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reduction of Environmental Tobacco Smoke (ETS) Exposure In Pediatric Cancer Patients
NCT00766766
A Study of Tobacco Smoke and Children With Respiratory Illnesses
NCT03062709
Clinical Response to Biomarker Documentation of Child Secondhand Smoke Exposure
NCT01145729
Computer-Based Program to Facilitate Readiness and Motivation for Smoking Cessation
NCT01326234
The Feasibility of Text Messaging to Assess Secondhand Smoke Exposure Among Youngsters With Cancer or Sickle Cell Disease
NCT01591187
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary objective of this study is to determine if providing urine cotinine feedback to caregivers in conjunction with standard education will be more effective than education alone in reducing patient SHS exposure.
The secondary objectives of this study are:
To determine whether urine cotinine feedback in conjunction with education provided to the caregiver is more effective in changing parental smoking behavior compared to education alone.
As an exploratory measure we will collect history and physical exam data to follow patient's clinical complications during the study to determine if patients with a decrease in SHS exposure also have a decrease in clinical complications.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active Intervention
Those randomized to the active intervention will receive education about secondhand smoke exposure and feedback using the cotinine test strip.
Education
Participants in both groups will receive education by the EPA on the danger of exposure to secondhand smoke and how exposure can be prevented.
Cotinine Education
Those randomized to the active intervention will also be provided with education utilizing the cotinine test strip in conjunction with the education from the EPA.
Education only
Those randomized to the education only group will receive only the education about secondhand smoke exposure.
Education
Participants in both groups will receive education by the EPA on the danger of exposure to secondhand smoke and how exposure can be prevented.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Education
Participants in both groups will receive education by the EPA on the danger of exposure to secondhand smoke and how exposure can be prevented.
Cotinine Education
Those randomized to the active intervention will also be provided with education utilizing the cotinine test strip in conjunction with the education from the EPA.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Currently undergoing treatment for cancer at the time of enrollment, at least 28 days post diagnosis.
* The child must reside 5 days a week with a household smoker (defined as a person who smokes greater than 10 cigarettes daily).
* Child must be potty trained.
* Parent/Legal Guardian ≥ 18 years of age.
* Parent/Legal Guardian who accompanies the child to the first visit must accompany the child to all other visits. This person does not need to be the household smoker, but must be willing to educate the smoker on results at the visit and take the education handout home to them.
* Parent/Legal Guardian must have a working phone to complete the week 5 follow-up phone call.
* Able and willing to sign informed consent/assent.
* Signed HIPAA compliant research authorization.
Exclusion Criteria
* Inability to perform the initial cotinine test.
2 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
University of South Florida
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marisa Couluris, DO
Role: STUDY_CHAIR
University of South Florida
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alfred I. duPont Hospital for Children
Wilmington, Delaware, United States
Lee Memorial Hospital - The Golisano Children's Hospital of Southwest Florida
Fort Myers, Florida, United States
Nemours Children's Clinic
Jacksonville, Florida, United States
Nemours Children's Hospital
Orlando, Florida, United States
Nemours Children's Clinic
Pensacola, Florida, United States
All Children's Hospital
Saint Petersburgh, Florida, United States
Tampa General Hospital
Tampa, Florida, United States
Columbia University Medical Center
New York, New York, United States
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
St. Vincent Hospital
Green Bay, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SCUSF 1201
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.